The failure of lawmakers to resolve the debt crisis over the weekend sent the markets tumbling to a lower open with the Dow dropping 79 points to 15,158. Nasdaq lost 14 points to 3777.
On the upside
The Food and Drug Administration approved Antares Pharma's (Nasdaq: ATRS) rheumatoid arthritis treatment OTREXUP.
Wedbush analyst Betsy Van Hees upgraded Advanced Micro Devices (NYSE: AMD) from a Neutral rating to an Outperform rating.
Wells Fargo upgraded Liberty Interactive (Nasdaq: LINTA) from a Market Perform rating to an Outperform rating.
On the downside
Coronado Biosciences (Nasdaq: CNDO) reported disappointing results from a Phase 2 TRUST-1 clinical trial for its Crohn's disease treatment TSO.
Deutsche Bank analyst Ross Sandler downgraded Expedia (Nasdaq: EXPE) from a Buy rating to a Hold rating and cut his price target from $66 to $51.
Oppenheimer lowered its price target on Amarin (Nasdaq: AMRN).
In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by nearly 3 to 1 on Nasdaq. The broader S&P 500 lost 9 points to 1694.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here